We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
142 hedge funds and large institutions have $2B invested in Lexicon Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
273% more call options, than puts
Call options by funds: $18.4M | Put options by funds: $4.94M
43% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 40
25% more capital invested
Capital invested by funds: $1.59B → $2B (+$406M)
25% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 20
4% more funds holding
Funds holding: 137 → 142 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
142
Holders Change
+5
Holders Change %
+3.65%
% of All Funds
3.79%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
25
Increased
57
Reduced
40
Closed
20
Calls
$18.4M
Puts
$4.94M
Net Calls
+$13.5M
Net Calls Change
+$9.65M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$11.9M |
| 2 |
CCI
Columbus Circle Investors
|
+$8.88M |
| 3 |
D.E. Shaw & Co
New York
|
+$7.56M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.97M |
| 5 |
KCM
Kingdon Capital Management
New York
|
+$5.07M |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
-$28.6M |
| 2 |
BM
Bridger Management
New York
|
-$11.2M |
| 3 |
HW
Hancock Whitney
Gulfport,
Mississippi
|
-$9.53M |
| 4 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$4.13M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$3.98M |
